LOGIN
ID
PW
MemberShip
2025-07-16 04:58
All News
Policy
Company
Product
Opinion
InterView
°Ë»ö
Dailypharm Live Search
Close
Product
The KPA establishes an emergency TFT
by
Apr 20, 2022 06:05am
As the presidential transition committee is expected to include the permission of non-face-to-face medical treatment in its national agenda and fully review the revision of the law, the KPA has begun to come up with measures. The Chairman Choi Kwang-hoon formed a TFT related to non-face-to-face treatment and convened his first meeting toda
Product
Non-face-to-face tx companies are appealing for regulations
by
Jung, Heung-Jun
Apr 20, 2022 06:05am
Non-face-to-face treatment companies are appealing for regulatory improvement ahead of the abolition of social distancing and easing the level of infectious diseases. Pharmacists are protesting that the reason for non-face-to-face is disappearing and that they should take steps to temporarily terminate the permit as scheduled. According to th
Product
Immunity products fare better ¡°targeting the long COVID mkt
by
Apr 19, 2022 05:52am
The OTC drug trend at pharmacies is changing. Compared to February and March when the Omicron variant had wielded power over the country and sales at pharmacies increased due to a surge in demand for antipyretic analgesics and sore throat treatments, etc., sales of products related to long-term effects of COVID-19 are now increasing due to more
Product
Gov discusses presenting regulatory sandboxes for ER OTC
by
Jung, Heung-Jun
Apr 18, 2022 05:57am
The Ministry of Trade, Industry and Energy conducted an opinion survey of government departments on regulatory sandbox agendas related to safety medicines (medications that are urgently used for mild symptoms among general drugs and can be used by patients themselves). If discussions on special regulations on safety medicines begin following
Product
Lagevrio prescriptions exceed 2,000¡¦ Paxlovid's up 25.6%
by
Kang, Shin-Kook
Apr 5, 2022 05:58am
The number of oral COVID-19 treatment Largevrio¡¯s prescriptions has exceeded 2,000 in only 5 days since it was supplied to pharmacies in Korea. Also, the number of total Paxlovid prescriptions has exceeded 150,000 courses. According to the Korea Disease Control and Prevention Agency on the 1st, a total of 150,321 prescriptions were made fro
Product
Only Paxlovid's prescription continues instead of Lagevrio
by
Jung, Heung-Jun
Mar 29, 2022 05:54am
Lagevrio, a Merck coronavirus PO treatment, has been supplied to pharmacies since the 26th, but has not yet been prescribed. According to pharmacies on the 28th, no code has been registered in the billing program. Pharmacy A in Seoul said, "In the case of clinics, prescriptions will only be possible if they are prescribed by hand," adding,
Product
Butterfly effect caused by brand name purchase
by
Kim JiEun
Mar 23, 2022 05:50am
From Rx drugs to OTC drugs, front-line pharmacies have recently had much time since the outbreak of COVID-19. Some say that pharmacy sales are also the biggest boom since the division of labor. Obviously, sales of generic drugs for certain diseases in most pharmacies have increased. However, pharmacists point out that there are concerns ab
Product
Paxlovid shortage to be resolved with Molnupiravir approval?
by
Jung, Heung-Jun
Mar 21, 2022 05:55am
The shortage of Paxlovid at pharmacies is expected to be partially resolved with the government's emergency approval of Merck (MDS)¡¯s oral COVID-19 treatment ¡®molnupiravir.¡¯ On the 18th, the Central Disease Control Headquarters had announced that 88,276 courses of Paxlovid remain in stock in Korea. Also, with the grant of RAT(rapid ant
Product
Defective tablets of Lipitor were found
by
Kim JiEun
Feb 8, 2022 05:54am
Defective drugs have been found one after another in Lipitor, one of the most frequent prescription drugs, requiring caution when preparing. According to a pharmacist in Seoul on the 3rd, a defective tablet was recently found in a bottle of Lipitor again following November last year. The pharmacist said he found a suspicious substance wh
Product
Actinum is a troublemaker?
by
Kim JiEun
Feb 7, 2022 05:57am
Actinum is out of stock due to lack of inventory. The key is to return distribution inventory after the 11th. Multivitamin Actinum, which ambitiously entered Korea, is in a position to become a headache. It is not expected to be easy to order at pharmacies for the time being. According to an official at Dongwha Pharm on the 14th, Actinum'
1
2
3
4
5
6
7
8
9
10
>